Verzenio (abemaciclib tablets) — Cigna
Endometrial Cancer
Initial criteria
- Patient age ≥ 18 years
- Patient has recurrent or metastatic disease
- Patient has estrogen receptor (ER)-positive tumors
- Verzenio will be used in combination with letrozole
Approval duration
1 year